Clinical Trial Update: Efficacy and Safety of Recombinant Human Endostatin in Non-Small Cell Lung Cancer With Leptomeningeal Metastasis [Phase 4]

View source ↗

Summary

Clinical trial update evaluating recombinant human endostatin for leptomeningeal metastasis in non-small cell lung cancer (Phase 4) with efficacy and safety dat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leptomeningeal Metastasis
• Non-small Cell Lung Cancer

Drugs mentioned

• Recombinant human endostatin (recombinant human endostatin)

Snippet

Sponsor: Hui Bu | Conditions: Leptomeningeal Metastasis | Phase 4 | Status: UNKNOWN